title: Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries.
abstract: Cervical cancer and other human papillomavirus- (HPV-) related cancers are preventable, but preventive measures implemented in developing countries and especially in low-income rural regions have not been effective. Cervical cancer burden derived from sexually transmitted HPV infections is the heaviest in developing countries, and a dramatic increase in the number of cervical cancer cases is predicted, if no intervention is implemented in the near future. HPV vaccines offer an efficient way to prevent related cancers. Recently implemented school-based HPV vaccination demonstration programmes can help tackle the challenges linked with vaccine coverage, and access to vaccination and health services, but prevention strategies need to be modified according to regional characteristics. In urban regions WHO-recommended vaccination strategies might be enough to significantly reduce HPV-related disease burden, but in the rural regions additional vaccination strategies, vaccinating both sexes rather than only females when school attendance is the highest and applying a two-dose regime, need to be considered. From the point of view of both public health and ethics identification of the most effective prevention strategies is pivotal, especially when access to health services is limited. Considering cost-effectiveness versus justice further research on optional vaccination strategies is warranted.
authors.affiliation: School of Health Sciences, University of Tampere, Tampere, Finland. kari.natunen@uta.fi
authors.forename: Kari
authors.initials: K
authors.lastname: Natunen
authors.forename: Johannes
authors.initials: J
authors.lastname: Lehtinen
authors.forename: Proscovia
authors.initials: P
authors.lastname: Namujju
authors.forename: John
authors.initials: J
authors.lastname: Sellors
authors.forename: Matti
authors.initials: M
authors.lastname: Lehtinen
mesh_terms: D019496:Cancer Vaccines / Q000008:administration & dosage*; D003906:Developing Countries; D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology*
chemical_list: D019496:Cancer Vaccines; D053918:Papillomavirus Vaccines